Results 231 to 240 of about 180,059 (262)
Some of the next articles are maybe not open access.
Targeting miR-30d reverses pathological cardiac hypertrophy
EBioMedicine, 2022Jianhua Yao, Saumya Das, Junjie Xiao
exaly
Mechanisms for the transition from physiological to pathological cardiac hypertrophy
Canadian Journal of Physiology and Pharmacology, 2020Todd A Duhamel, Christopher Oldfield
exaly
Mechanisms of physiological and pathological cardiac hypertrophy
Nature Reviews Cardiology, 2018Michinari Nakamura, Junichi Sadoshima
exaly
The pathogenesis of cardiac hypertrophy
Progress in Cardiovascular Diseases, 1962openaire +2 more sources
CARDIAC HYPERTROPHY IN OLD AGE
The Lancet, 1989BENTIVOGLIO, Maurizio +4 more
openaire +3 more sources
SIRT2 Acts as a Cardioprotective Deacetylase in Pathological Cardiac Hypertrophy
Circulation, 2017Hou-zao Chen, De-Pei Liu, Ming-Hui Zou
exaly
Endonuclease G is a novel determinant of cardiac hypertrophy and mitochondrial function
Nature, 2011Stuart Cook, Michal Pravenec
exaly